Identifying potential targets for preventing cancer progression through the PLA2G1B recombinant protein using...

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Lung cancer remains a leading cause of cancer-related mortality worldwide.
• Identifying novel molecular targets is crucial for advancing lung cancer diagnosis and therapy.
• Phospholipase A2 group IB (PLA2G1B) is implicated in lipid metabolism and inflammation, suggesting a role in cancer.

Purpose of the Study:

• To investigate the molecular structure of PLA2G1B for targeted therapeutic interventions.
• To identify key genes and pathways associated with lung cancer development.
• To evaluate the potential of PLA2G1B as a preventative target for lung cancer.

Main Methods:

• Recombinant protein structure analysis of PLA2G1B.
• Construction of protein-protein interaction networks using R's STRING program.
• Application of LASSO, SVM-RFE, and RF algorithms to identify lung cancer-associated genes.
• Gene Set Enrichment Analysis (GSEA) to explore molecular pathways.

Main Results:

• Novel therapeutic strategies targeting PLA2G1B structure were designed.
• Key genes related to adhesion and neuroactive ligand-receptor interactions were identified.
• PLA2G1B was identified as a potential preventative factor, closely linked to alpha-linolenic acid metabolism.

Conclusions:

• PLA2G1B plays a significant role in lung cancer, offering a potential target for novel therapies.
• The study identified PLA2G1B as a potential preventative gene for lung cancer.
• Targeting PLA2G1B may impede tumor growth and provide new avenues for lung cancer prevention and treatment.